Ligand · DT5
DT5 · 4-{[5-(cyclohexyloxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide
DT5, 4-{[5-(cyclohexyloxy)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide (C17 H20 N6 O3 S, 388.4 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within…
- Component
- DT5
- Formula
- C17 H20 N6 O3 S
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
DT5 in 4 structures; the first of them:
- 2C6M · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT5 A1297 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 10 more
- 2C6T · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT5 A1297 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, VAL64, PHE80 and 12 more
- 2C6M · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT5 A1297 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 10 more
- 2C6T · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT5 A1297 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, VAL64, PHE80 and 12 more
Residues it binds most
GLN 6, GLU 6, LEU 6, PHE 6, VAL 6, ALA 6, ASP 6, GLY 6, LYS 6, HIS 6 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.